Altamira Therapeutics Stock (NASDAQ: CYTO) stock price, news, charts, stock research, profile.
Open | $1.40 |
Close | $1.40 |
Volume / Avg. | 23.17K / 957.27K |
Day Range | 1.39 - 1.42 |
52 Wk Range | 1.05 - 17.20 |
Market Cap | $3.66M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 5.21% |
Days to Cover | 2.04 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Altamira Therapeutics (NASDAQ:CYTO) through any online brokerage.
Other companies in Altamira Therapeutics’s space includes: Cingulate (NASDAQ:CING), Processa Pharma (NASDAQ:PCSA), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD) and Titan Pharma (NASDAQ:TTNP).
There is no analysis for Altamira Therapeutics.
There is no analysis for Altamira Therapeutics to provide a consensus price target.
The stock price for Altamira Therapeutics (NASDAQ: CYTO) is $1.37 last updated July 17, 2024 at 7:51 AM EDT.
There are no upcoming dividends for Altamira Therapeutics.
Altamira Therapeutics’s H1 earnings are confirmed for Tuesday, September 10, 2024.
There is no upcoming split for Altamira Therapeutics.
Altamira Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.